Corcept Therapeutics Incorporated (CORT)

Interest coverage

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm)	US$ in thousands	107,282	98,112	98,869	100,718	112,634	126,799	131,097	131,608	124,477	118,323	106,810	110,129	128,202	132,708	140,993	130,364	111,609	101,491	91,456	87,457
Interest expense (ttm)	US$ in thousands	0	-1,804	-734	-104	3,557	1,852	854	334	529	754	1,304	2,204	3,400	4,547	5,273	5,441	5,067	4,665	4,076	3,460
Interest coverage		—	—	—	—	31.67	68.47	153.51	394.04	235.31	156.93	81.91	49.97	37.71	29.19	26.74	23.96	22.03	21.76	22.44	25.28

December 31, 2023 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $107,282K ÷ $0K
= —

The lack of data for the interest coverage ratio for Corcept Therapeutics Inc across all quarters of the years 2022 and 2023 impedes a detailed and comprehensive analysis at this time. It is important to note that the interest coverage ratio is a key financial metric that indicates a company's ability to meet its interest obligations using its earnings. Further information or data points would be required to assess the company's financial health and performance in terms of managing its interest expenses effectively.